Clinical News: Page 1428

Are additional spot views after tomosynthesis necessary?
By Kate Madden Yee
Tuesday, December 2 | 11:50 a.m.-12:00 p.m. | VSBR31-17 | Arie Crown TheaterTomosynthesis has been shown to reduce recalls from screening mammography and to be equivalent to or better than conventional spot views. So how necessary are additional spot tomosynthesis views when women have been recalled after screening? Researchers from Yale University will address this question during this Tuesday session.
November 11, 2014
Breast MRI rules out malignancy in BI-RADS 0 cases
By Kate Madden Yee
Tuesday, December 2 | 11:40 a.m.-11:50 a.m. | SSG01-08 | Room E451ABreast MR reliably rules out malignancy in conventional BI-RADS 0 cases, researchers from Vienna have found.
November 11, 2014
Synthetic 2D for tomo performs comparably to conventional mammo
By Kate Madden Yee
Tuesday, December 2 | 11:00 a.m.-11:10 a.m. | VSBR31-12 | Arie Crown TheaterSynthetic 2D mammography used with digital breast tomosynthesis (DBT) performs just as well as conventional 2D mammography and DBT, which suggests that the technology can reduce women's radiation exposure, according to Italian researchers.
November 11, 2014
Breast thickness not density boosts radiation dose at DBT
By Kate Madden Yee
Tuesday, December 2 | 10:00 a.m.-10:10 a.m. | VSBR31-08 | Arie Crown TheaterBreast tissue thickness at compression should be considered with patients undergoing digital breast tomosynthesis (DBT), as it can contribute to higher radiation doses, according to this presentation to be given Tuesday morning.
November 11, 2014
How does DBT affect BI-RADS 3 lesions?
By Kate Madden Yee
Monday, December 1 | 3:30 p.m.-3:40 p.m. | SSE02-04 | Room E450ADigital breast tomosynthesis (DBT) is rapidly becoming a key part of breast cancer diagnosis and will likely redefine BI-RADS criteria, particularly the BI-RADS 3 category of "probably benign lesions," according to researchers from Yale University.
November 11, 2014
DBT calls breast MR's staging role into question
By Kate Madden Yee
Monday, December 1 | 3:20 p.m.-3:30 p.m. | SSE02-03 | Room E450AHow useful is MR in staging newly diagnosed breast cancer detected by digital breast tomosynthesis (DBT)? It's a question that needs to be considered, according to researchers from the University of Pennsylvania.
November 11, 2014
Tomo shows promise for preoperative evaluation
By Kate Madden Yee
Monday, December 1 | 3:10 p.m.-3:20 p.m. | SSE02-02 | Room E450ADigital breast tomosynthesis shows promise for preoperatively identifying additional lesions in women newly diagnosed with breast cancer, according to this Monday afternoon presentation.
November 11, 2014
DBT plus FFDM and ultrasound improves diagnostic workup accuracy
By Kate Madden Yee
Monday, December 1 | 12:45 p.m.-1:15 p.m. | BRS254 | Lakeside Learning CenterAdding digital breast tomosynthesis (DBT) to full-field digital mammography (FFDM) and ultrasound improves the diagnostic accuracy of breast lesion workup, according to researchers from King's College Hospital in London.
November 11, 2014
Breast MR helps track women with premenopausal cancer history
By Kate Madden Yee
Monday, December 1 | 11:30 a.m.-11:40 a.m. | VSBR21-15 | Arie Crown TheaterBreast MR is helpful for tracking women with a history of premenopausal breast cancer, which is especially important as these women are at increased risk for a second breast cancer diagnosis, according to a new study.
November 11, 2014
Abridged breast MR protocol matches traditional exam
By Kate Madden Yee
Monday, December 1 | 11:20 a.m.-11:30 a.m. | VSBR21-14 | Arie Crown TheaterAn abridged breast MR protocol works just as well as a conventional exam, according to a study to be presented by researchers from New York University.
November 11, 2014
Is it possible to avoid unnecessary follow-up after screening ultrasound?
By Kate Madden Yee
Sunday, November 30 | 1:00 p.m.-1:30 p.m. | BRS244 | Lakeside Learning CenterIs it possible to minimize unnecessary follow-up in women who have BI-RADS 3 lesions at screening ultrasound? Yes, according to research that will be presented in this Sunday poster session.
November 11, 2014
How well does PET/MR confirm cervical cancer treatment response?
By Kate Madden Yee
Sunday, November 30 | 12:30 p.m.-1:00 p.m. | GUS102 | Lakeside Learning CenterHow well does PET/MR correlate with response to treatment in women with advanced cervical cancer? Researchers from the University of North Carolina at Chapel Hill will address this question on Sunday.
November 11, 2014
Previous Page
Page 1428 of 3671
Next Page